Astria Therapeutics, Inc. Operating Lease Right-of-Use Assets
Astria Therapeutics, Inc. had Operating Lease Right-of-Use Assets of $4.25 million as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2025-11-12
- 2025-09-30: Operating Lease, Right-of-Use Asset $4.25M.
- 2025-06-30: Operating Lease, Right-of-Use Asset $4.55M.
- 2025-03-31: Operating Lease, Right-of-Use Asset $4.83M.
- 2024-12-31: Operating Lease, Right-of-Use Asset $5.11M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2025-09-30 | $4.25M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $4.55M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $4.83M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $5.11M 10-Q · filed 2025-11-12 |
| 2024-09-30 | $5.39M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $5.71M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $210.00K 10-Q · filed 2024-05-09 |
| 2024-01-31 | $5.80M 10-Q · filed 2025-11-12 |
| 2024-01-03 | $5.80M 10-Q · filed 2025-05-13 |
| 2023-12-31 | $363.00K 10-K · filed 2025-03-11 |
| 2023-09-30 | $514.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $661.00K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $806.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $948.00K 10-K · filed 2024-03-04 |
| 2022-09-30 | $1.09M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $1.28M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $228.00K 10-Q · filed 2022-05-12 |
| 2022-01-28 | $1.30M 10-K · filed 2023-03-22 |
| 2021-12-31 | $394.00K 10-K · filed 2023-03-22 |
| 2021-09-30 | $557.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $717.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $874.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $966.00K 10-K · filed 2022-03-10 |
| 2020-09-30 | $1.18M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $1.33M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $1.80M 10-Q · filed 2020-05-12 |
| 2019-12-31 | $2.35M 10-K/A · filed 2021-04-19 |
| 2019-11-30 | $1.70M 10-K · filed 2022-03-10 |
| 2019-09-30 | $965.00K 10-Q · filed 2019-11-07 |